Lavelle Erin

Director · JBIO, AVLN

As of 2026-09-16, Lavelle Erin has 3 Form 4 transactions on record across 2 companies — 2 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $1.5MIndirect: $0$1.5Mas of 2026-09-16
  • Direct $1.5M
  • Indirect $0
AVLNdirect26,978 sh$936K
JBIOdirect34,843 sh$580K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

JBIO · 2 trades
2026-06-09: Award / grant, 34,843 sh ($0)2025-04-29: Award / grant, 23,017 sh ($0)
AVLN · 1 trade
2026-04-30: Award / grant, 26,978 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
3 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-06-09JBIOAward / grant34,84334,843Form 4
2026-04-30AVLNAward / grant26,97826,978Form 4
2025-04-29JBIOAward / grant23,01723,017Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.